Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: penn  medicine  cancer  research  study  immune  cells  leukemia  patients  cellular  therapy  health  multivu  64691  music  technology  babies  woman  communication  pregnancy  mother  research  children  sound  multivu  7647351  liposonix  solta  medical  fractional  resurfacing  non-invasive  skin  tightening  hifu  technology  treatments  multivu  54037  sickle  cell  disease  health  wellness  treatment  medical  hospital  scd  research  multivu  7903251  cancer  kids  childhood  micah  awareness  st  baldrick  foundation  research  health  medical  multivu  8284352  saint  jude  childrens  research  hospital  childhood  cancer  patients  health  treatment  multivu  7532851  pancreatic  cancer  health  disease  symposium  awareness  treatments  survivors  multivu  8213752  cancer  leukemia  lymphoma  lls  health  healthcare  cure  treatment  aml  multivu  7554854  orbis  hospital  flying  eye  air  flight  plane  healthcare  health  sight  multivu  7316251  phrma  women  health  medical  research  meds  medicine  diseases  depression  cancer  clinical  trials  fda  multivu  50270  veripsych  rules-based  medicine  rbm  schizophrenia  diagnostic  test  tool  healthcare  multivu  46237  miramar  labs  miradry  system  treatment  primary  axillary  hyperhidrosis  excessive  underarm  sweat  glands  multivu  54021 
Search // clinical
Results 61-72 of 101 for ' clinical ' (0 seconds)
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced a collaboration with Atigeo™, a compassionate technology company that turns science into products and services for a wiser world. Together, Emdeon and Atigeo plan to explore the use of intelligent analytics layered on top of petabytes of healthcare data to improve health outcomes. To view Multimedia News Release, go to http://www.multivu.com/mnr/59755-emdeon-and-atigeo-intelligent-analytics-for-health-outcomes-himss13
Categories // Business  Science and Technology 
Added: 4263 days ago by MultiVuVideos
Runtime: 1m21s | Views: 2609 | Comments: 1
Not yet rated
 

 

 

Soy consumption is up 14 percent since 2011,26 yet confusion lingers over soy’s role in everything from human health to food production. To clear up misperceptions, the United Soybean Board (USB) busts five common soy myths with science-backed facts on SoyConnection.com/soy-wisdom. 1) Eating soy does not increase breast cancer risk. Clinical studies show soy isoflavone exposure does not adversely affect breast tissue as assessed by markers of breast cancer risk, such as breast cell proliferation.1–7 The American Institute for Cancer Research and the American Cancer Society say that women who have been diagnosed with breast cancer can safely consume soyfoods. In fact, the World Cancer Research Fund International has identified a link between soy consumption and an improved survival of breast cancer patients.8-9 “Not only does evidence indicate soyfoods may benefit women with breast cancer, but consuming soy when young helps prevent the onset of this disease later in life27-30,” stated Mark Messina, Ph.D., who has dedicated the past 30 years to understanding the health effects of soyfoods. To view the multimedia release go to: http://www.multivu.com/players/English/7877951-united-soybean-board-top-soy-myths/
Categories // Miscellaneous 
Added: 3003 days ago by MultiVuVideos
Runtime: 2m29s | Views: 739 | Comments: 0
Not yet rated
 

 

 

Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and haemodynamic monitoring, announced the results of a pivotal clinical study of high-risk surgical patients with severe aortic stenosis treated in Cohort A of The PARTNER Trial. These data demonstrate that the study achieved its primary endpoint at one year, concluding that survival of patients treated with the Edwards SAPIEN transcatheter aortic valve was equivalent to those treated with surgical aortic valve replacement. The data were presented at the American College of Cardiology’s (ACC) 60th Annual Scientific Session & Expo in New Orleans, LA, USA. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/edwardslifesciences/48895/
Categories // Science and Technology 
Added: 4959 days ago by MultiVuVideos
Runtime: 2m16s | Views: 8081 | Comments: 0
Not yet rated
 

 

 

For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence of safety and effectiveness for a new, FDA-approved medical device. Torax Medical’s LINX® Reflux Management System was studied in a controlled, prospective, multicenter trial involving 14 U.S. and European medical centers as part of the FDA pre-market approval process. The patients were evaluated before and after treatment to determine the effect of the LINX System on their GERD using pre-defined success criteria, which included reduction of esophageal acid, improvement in quality of life and elimination of reflux medications. To view Multimedia News Release, go to http://www.multivu.com/mnr/60077-torax-medical-linx-reflux-management-system-clinical-study-published
Added: 4270 days ago by MultiVuVideos
Runtime: 4m58s | Views: 1336 | Comments: 0
Not yet rated
 

 

 

“Be Youthful: Look Good, Feel Great – and Remain Young at Any Age,” Dr. Shino Bay Aguilera’s most recent publication in English, was just published in Spanish and is available on Amazon.com, through barnesandnoble.com, and electronically for Kindle. In addition, major bookstores in the United States can provide home delivery for individual orders. The book provides insights and tips on the perfect ways to renew and restore your mind, body and, spirit – and describes what it means to actually be “youthful.” Dr. Shino Bay Aguilera is a world-renowned cosmetic and clinical dermatologist and the owner of the Shino Bay Cosmetic Dermatology, Plastic Surgery & Laser Institute. He is known as the #1 injector of Sculptra® in the United States and as the preferred choice of celebrities and public figures. Dr. Aguilera, originally from Panama and a former clothing model, became intrigued by people’s everlasting pursuit of the “fountain of youth” through his consultations. “Be Youthful” explores the many ways to clinically appear youthful, but also details his personal journey about the pursuit of happiness, peace, and self-confidence, which all lead to beauty. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7513051-dr-shino-bay-aguilera-book-be-youthful/
Categories // People and Blog 
Added: 3466 days ago by MultiVuVideos
Runtime: 7m13s | Views: 992 | Comments: 2
Not yet rated
 

 

 

A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma. The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor. To view the multimedia release go to: https://www.multivu.com/players/English/7944251-northwestern-medicine-stem-cell-trial/
Categories // Miscellaneous 
Added: 2688 days ago by MultiVuVideos
Runtime: 4m28s | Views: 647 | Comments: 1
Not yet rated
 

 

 

Findings from continued clinical studies of investigational chimeric antigen receptor (CAR) therapy, CTL019, demonstrate its potential role in the treatment of certain types of lymphocytic leukemia. In one long-term study of pediatric patients with acute lymphoblastic leukemia (ALL), results showed that 36 of 39 pediatric patients with relapsed/refractory (r/r) ALL, or 92%, experienced complete remissions (CR) with CTL0191. To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7393851-novartis-new-ctl019-clinic-data-acute-lymphoblastic-leukemia/
Categories // Miscellaneous 
Added: 3614 days ago by MultiVuVideos
Runtime: 1m8s | Views: 891 | Comments: 0
Not yet rated
 

 

 

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
Categories // News and Politics 
Added: 4905 days ago by MultiVuVideo
Runtime: 2m15s | Views: 7329 | Comments: 0
Not yet rated
 

 

 

On June 5, CVS/pharmacy kicked-off its 10th annual in-store fundraising campaign -- “Researching a Cure” -- to support the fight against amyotrophic lateral sclerosis (ALS). Funds raised through the campaign benefit the ALS Therapy Alliance (ATA), a leading organization dedicated to advancing ALS research. Through the Researching a Cure campaign, CVS/pharmacy has raised more than $23 million in its stores and online at www.cvs.com, to fund new clinical research with the aim of discovering a treatment or cure for ALS. The 2011 campaign will run through June 25. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cvs/50475/
Categories // News and Politics 
Added: 4896 days ago by MultiVuVideo
Runtime: 3m24s | Views: 9527 | Comments: 0
Not yet rated
 

 

 

An expert group of specialists have come together to develop three new educational resources: the Journal of Perioperative Medicine, the Journal of Neonatal Intensive Care and an open-access online portal. These resources provide practical advice on key clinical issues, tackle controversial topics on which a consensus is needed, and highlight clinical concerns that need to be addressed in clinical practice. These resources are available through a new educational initiative called Cure&Care and are accessible at: www.cureandcareportal.com. Cure&Care officially launches at Euroanaesthesia 2014, in Stockholm, Sweden, 30 May – 3 June. To view the Multimedia News Release, go to http://www.multivu.com/mnr/71400535-cure-care-new-educational-initiative
Categories // Science and Technology 
Added: 3808 days ago by MultiVuVideos
Runtime: 4m11s | Views: 711 | Comments: 1
Not yet rated
 

 

 

More than eight in 10 Americans ages 50-64 believe healthy teeth and gums are essential to maintaining overall good health, yet only a third say they are taking good care of their oral health, according to a survey conducted by the American Dental Association (ADA), with Crest® and Oral-B®. To help bridge this gap, Crest Pro-Health and actress, author, and health advocate Marilu Henner are committed to educating older adults about the importance of gum health during the 2nd annual National Gingivitis Awareness Month this September. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/crestprohealth/49093/
Categories // Event and Party  Business 
Added: 4787 days ago by MultiVuVideos
Runtime: 2m42s | Views: 7376 | Comments: 2
Not yet rated
 

 

 

On September 15th, Crest and Oral-B announced the kick off of National Gingivitis Awareness Month, with a press conference in Greeley Square Park, Manhattan, featuring “White Collar” star, Tiffani Thiessen. Thiessen is helping Crest and Oral-B to bring attention to the early gum disease, gingivitis, which affects more than fifty percent of American adults¹. Along with the declaration, Crest and Oral-B are helping consumers prevent and reverse gingivitis by introducing a new member to the Crest® Pro-Health® family, Crest® Pro-Health® Clinical Gum Protection. The new, advanced formula of Clinical Gum Protection provides Crest’s highest level of protection against the plaque bacteria that can cause gingivitis and with regular use, is clinically proven to help reverse gingivitis in just four weeks. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/crestprohealth/44592/
Categories // News and Politics 
Added: 5158 days ago by MultiVuVideo
Runtime: 1m1s | Views: 18935 | Comments: 0
Not yet rated
 

 

 

Page 6 of 9  |  Go to page     |  ««FIRST «Previous  Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.